首页> 外国专利> Combination therapy of cancer with anti-thygline antibodies and anti-VEGF agents

Combination therapy of cancer with anti-thygline antibodies and anti-VEGF agents

机译:抗胸腺肽抗体和抗VEGF药物联合治疗癌症

摘要

A method for inhibiting the outbreak of new vessels induced by VEGF by contacting cells in vitro with a composition comprising a chimeric antndoglin antibody and a composition comprising an antagonistic anti-VEGF antibody; said chimeric antndoglin antibody comprises a light chain variable region (VL) having an amino acid sequence that is exposed as sec. with no. of ident .: 1; a light chain constant region (CL) having an amino acid sequence that is exposed as sec. with no. of ident .: 2; a heavy chain variable region (VH) that has an amino acid sequence that is exposed as sec. with no. of ident .: 3; and a constant region (Fc) that has an amino acid sequence that is exposed as sec. with no. Ident .: 4.
机译:一种通过使细胞与包含嵌合antndoglin抗体的组合物和包含拮抗性抗VEGF抗体的组合物在体外接触来抑制由VEGF诱导的新血管发生的方法。所述嵌合的antndoglin抗体包含轻链可变区(VL),所述轻链可变区具有以sec暴露的氨基酸序列。没有。的身份。:1;轻链恒定区(CL),其氨基酸序列为sec。没有。的身份。:2;重链可变区(VH),其氨基酸序列为sec。没有。 :3;恒定区(Fc)的氨基酸序列为sec。没有。身份.. 4。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号